Sattva Neelapu

Sattva Neelapu

UNVERIFIED PROFILE

Are you Sattva Neelapu?   Register this Author

Register author
Sattva Neelapu

Sattva Neelapu

Publications by authors named "Sattva Neelapu"

Are you Sattva Neelapu?   Register this Author

100Publications

3651Reads

22Profile Views

CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era.

Leuk Lymphoma 2019 Sep 18:1-9. Epub 2019 Sep 18.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1663418DOI Listing
September 2019

Reply.

Biol Blood Marrow Transplant 2019 Jun 23;25(6):e211-e212. Epub 2019 Mar 23.

The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.03.019DOI Listing
June 2019

Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes.

Clin Lymphoma Myeloma Leuk 2019 Jun 26;19(6):381-389. Epub 2019 Feb 26.

Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.02.011DOI Listing
June 2019

Safety of CAR T-cell therapy in patients with B-cell lymphoma and chronic hepatitis B or C virus infection.

Blood 2019 Jun 17;133(26):2800-2802. Epub 2019 May 17.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019000888DOI Listing
June 2019

Managing the toxicities of CAR T-cell therapy.

Authors:
Sattva S Neelapu

Hematol Oncol 2019 Jun;37 Suppl 1:48-52

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2595DOI Listing
June 2019

Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma.

Leuk Lymphoma 2019 Jun 24:1-8. Epub 2019 Jun 24.

a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1627535DOI Listing
June 2019

Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?

Ann Hematol 2019 May 8;98(5):1169-1176. Epub 2019 Jan 8.

Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00277-018-3571-7
Publisher Site
http://dx.doi.org/10.1007/s00277-018-3571-7DOI Listing
May 2019

Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flare.

J Immunother Cancer 2019 May 14;7(1):126. Epub 2019 May 14.

Departments of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-019-0597-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518723PMC
May 2019

Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.

Br J Haematol 2019 Apr 5;185(2):334-338. Epub 2018 Jul 5.

Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15444DOI Listing
April 2019

CAR-T efficacy: is conditioning the key?

Authors:
Sattva S Neelapu

Blood 2019 Apr;133(17):1799-1800

The University of Texas MD Anderson Cancer Center

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2019-03
Publisher Site
http://dx.doi.org/10.1182/blood-2019-03-900928DOI Listing
April 2019

Chimeric Antigen Receptor-Engineered T Cell Therapy in Lymphoma.

Curr Oncol Rep 2019 Mar 27;21(5):38. Epub 2019 Mar 27.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 429, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-019-0789-zDOI Listing
March 2019

The promise of CAR T-cell therapy in aggressive B-cell lymphoma.

Best Pract Res Clin Haematol 2018 09 1;31(3):293-298. Epub 2018 Aug 1.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15216926183005
Publisher Site
http://dx.doi.org/10.1016/j.beha.2018.07.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594830PMC
September 2018

Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies .

Clin Cancer Res 2018 03 27;24(5):1114-1123. Epub 2017 Nov 27.

Beckman Research Institute City of Hope National Medical Center, Toni Stephenson Lymphoma Center, and Department of Hematology and Hematopoietic Stem Cell Transplantation, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1193DOI Listing
March 2018

CAR T-Cell Therapy in Large B-Cell Lymphoma.

N Engl J Med 2018 03;378(11):1065

Kite (Gilead), Santa Monica, CA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1800913DOI Listing
March 2018

Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.

BMC Cancer 2018 02 13;18(1):187. Epub 2018 Feb 13.

Toni Stephenson Lymphoma Center, Department of Hematology and Hematopoietic Stem Cell Transplantation, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-018-4094-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812202PMC
February 2018

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Nat Rev Clin Oncol 2018 Jan 19;15(1):47-62. Epub 2017 Sep 19.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733403PMC
January 2018

Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP.

Clin Lymphoma Myeloma Leuk 2018 01 14;18(1):e103-e108. Epub 2017 Nov 14.

Department of Lymphoma and Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.11.001DOI Listing
January 2018

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

N Engl J Med 2017 12 10;377(26):2531-2544. Epub 2017 Dec 10.

From the University of Texas M.D. Anderson Cancer Center, Houston (S.S.N., J.R.W.); H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (F.L.L., J.C.C.); Washington University and Siteman Cancer Center, St. Louis (N.L.B., A. Ghobadi); University of Miami, Miami (L.J.L., K.V.K.); Stanford University, Stanford (D.B.M., R.L.), City of Hope National Medical Center, Duarte (T.S.), University of California at Los Angeles, Los Angeles (J.M.T.), University of California at San Diego, San Diego (J.E.C.), and Kite Pharma, Santa Monica (A.B., J.R., L.N., Y.J., J.A., M.E., D.C., J.W., W.Y.G.) - all in California; Dana-Farber Cancer Institute, Boston (C.A.J., E.D.J.); Montefiore Medical Center, Bronx (I.B.), and the University of Rochester School of Medicine, Rochester (J.W.F., P.R.) - both in New York; Vanderbilt University Medical Center (O.O.O.) and the Sarah Cannon Research Institute and Tennessee Oncology (I.W.F.), Nashville; Mayo Clinic, Rochester, MN (Y.L., T.E.W.); Loyola University Medical Center, Maywood, IL (P.J.S.); John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ (A. Goy); Cleveland Clinic, Cleveland (B.T.H., M.R.S.); Karmanos Cancer Center, Wayne State University, Detroit (A.D.); University of Iowa Carver College of Medicine, Iowa City (U.F.); Colorado Blood Cancer Institute, Denver (P.M.S.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (J.M.); and Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (I.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1707447DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882485PMC
December 2017

Chimeric Antigen Receptor T Cells in Hematologic Malignancies.

Pharmacotherapy 2017 03 22;37(3):334-345. Epub 2017 Feb 22.

Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.1900DOI Listing
March 2017

Platelet activating factor-induced expression of p21 is correlated with histone acetylation.

Sci Rep 2017 02 3;7:41959. Epub 2017 Feb 3.

Department of Immunology and The Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep41959DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291204PMC
February 2017

An interim analysis of the ZUMA-1 study of KTE-C19 in refractory, aggressive non-Hodgkin lymphoma.

Authors:
Sattva S Neelapu

Clin Adv Hematol Oncol 2017 Feb;15(2):117-120

The University of Texas M.D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
February 2017

Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.

Clin Cancer Res 2017 Jan 24;23(1):181-192. Epub 2016 Jun 24.

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-3135DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433851PMC
January 2017

3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitro.

Lab Chip 2017 01;17(3):407-414

The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University, Atlanta, GA, USA. and The Parker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, GA, USA and Emory University School of Medicine, Department of Pediatrics, Division of Pediatric Hematology/Oncology, Atlanta, GA, USA and Children's Healthcare of Atlanta, Aflac Cancer & Blood Disorders Center, Atlanta, GA, USA and Institute of Electronics and Nanotechnology, Georgia Institute of Technology, Atlanta, GA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c6lc01204cDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5285444PMC
January 2017

IL-15 enhances the antitumor effect of human antigen-specific CD8 T cells by cellular senescence delay.

Oncoimmunology 2016 7;5(12):e1237327. Epub 2016 Oct 7.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1237327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215241PMC
October 2016

Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.

Sci Signal 2016 09 27;9(447):ra94. Epub 2016 Sep 27.

Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061503PMC
http://dx.doi.org/10.1126/scisignal.aaf3957DOI Listing
September 2016

Targeting B-cell malignancies through human B-cell receptor specific CD4 T cells.

Oncoimmunology 2016 19;5(11):e1232220. Epub 2016 Sep 19.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center , Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1232220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139634PMC
September 2016

Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment.

Oncotarget 2016 Mar;7(12):14350-65

Center for Stem Cell and Regenerative Disease, Brown Foundation Institute of Molecular Medicine for The Prevention of Human Diseases (IMM), The University of Texas-Health Science Center at Houston, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924720PMC
March 2016

Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma.

Oncotarget 2016 Jan;7(3):3461-76

Department of Experimental Therapeutics, The University of Texas Health Science Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.6505DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823120PMC
January 2016

Cancer immunotherapy: Strategies for personalization and combinatorial approaches.

Mol Oncol 2015 Dec 23;9(10):2043-53. Epub 2015 Oct 23.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.10.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684975PMC
December 2015

Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma.

Br J Haematol 2015 Nov 27;171(4):463-70. Epub 2015 Jul 27.

Department of Lymphoma/Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13603DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278973PMC
November 2015

Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma.

Haematologica 2015 Nov 6;100(11):e454-7. Epub 2015 Aug 6.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.131144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825296PMC
November 2015

Targeting the tumor niche to treat cancer.

Proc Natl Acad Sci U S A 2015 Oct 8;112(42):12907-8. Epub 2015 Oct 8.

Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1517389112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620886PMC
October 2015

Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma.

Curr Opin Oncol 2015 Sep;27(5):384-91

Division of Cancer Medicine, Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000212DOI Listing
September 2015

Novel immunologic approaches in lymphoma: unleashing the brakes on the immune system.

Curr Oncol Rep 2015 Jul;17(7):30

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 429, Houston, TX, 77030, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11912-015-0456-y
Publisher Site
http://dx.doi.org/10.1007/s11912-015-0456-yDOI Listing
July 2015

Targeting Wnt pathway in mantle cell lymphoma-initiating cells.

J Hematol Oncol 2015 Jun 6;8:63. Epub 2015 Jun 6.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-015-0161-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460883PMC
June 2015

Mutations and microenvironment collude in FL.

Authors:
Sattva S Neelapu

Blood 2015 Jan;125(4):587-9

THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2014-12-61
Publisher Site
http://dx.doi.org/10.1182/blood-2014-12-615294DOI Listing
January 2015

Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.

Int J Cancer 2014 Dec 12;135(12):2834-46. Epub 2014 May 12.

Department of Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Center for Cancer Immunology Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ijc.28937
Publisher Site
http://dx.doi.org/10.1002/ijc.28937DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352105PMC
December 2014

Rush hour traffic: directing T cells to tumor.

J Natl Cancer Inst 2014 Nov 24;106(11). Epub 2014 Sep 24.

Department of Lymphoma and Myeloma and Center for Cancer Immunology Research, University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/dju301DOI Listing
November 2014

Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1 T-cell subsets.

Oncoimmunology 2014 Jan 14;3(1):e28101. Epub 2014 Feb 14.

Department of Lymphoma and Myeloma; The University of Texas M.D. Anderson Cancer Center; Houston, TX USA ; Center for Cancer Immunology Research; The University of Texas M.D. Anderson Cancer Center; Houston, TX USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/onci.28101
Publisher Site
http://dx.doi.org/10.4161/onci.28101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011813PMC
January 2014